Suggestions
Journal Information
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
Cite
Cite
Share
Download PDF
More article options
Vol. 30. Issue S1.
XXIV Brazilian Congress of Infectious Diseases 2025
(March 2026)
771
Full text access

GUT MICROBIOTA AS A RESERVOIR OF DIFFERENT CARBAPENEMASE GENES IN GRAM-NEGATIVE BACILLI RECOVERED FROM HOSPITALIZED PATIENTS

Visits
533
Lucas Guilherme Toshio Takeuti Wadaa,
Corresponding author
lgttwada@gmail.com

Corresponding author:
, Heloisa Moreira Dias Pereiraa, Mirian Nicéa Zarpellonb, Nathalie Kira Tamurab, Hilton Vizzi Martinezb, Rafael Renato Brondani Moreiraa, Sheila Alexandra Belini Nishiyamaa, Maria Cristina Bronharo Tognima
a Universidade Estadual de Maringá (UEM), Maringá, PR, Brazil
b Hospital Universitário Regional de Maringá (HUM), Maringá, PR, Brazil
This item has received
Article information
Special issue
This article is part of special issue:
Vol. 30. Issue S1

XXIV Brazilian Congress of Infectious Diseases 2025

More info
Introduction/Objectives

Balance in the gut microbiota (GM) provides benefits to the host; however, during hospitalization, with the use of antimicrobials, there is an imbalance in the GM, leading to a worse prognosis for the patient. The objective was to evaluate the frequency of carriage of more than one bacterial species and/or more than one resistance mechanism in patients during hospitalization.

Methodology

This is a retrospective study (08/14 to 07/25), conducted in a teaching hospital in Paraná. The analysis was based on molecular detection by multiplex PCR of carbapenemase genes (CG) in Gram-negative bacteria (GNB). Patients were included if they had positive rectal swab surveillance cultures (PRSSC) for at least two GNB of the same species (GNB=E) carrying different genes (CG#), or GNB of different species (GNB#E) carrying different CG (CG#) or the same genes (CG=). Isolates were identified by the automated Phoenix-BD system. All identification and susceptibility testing data were retrieved from the Epicenter system.

Results

During the analyzed period, a total of 1,207 isolates carrying CG from 948 patients were recovered. Of these, 112 patients with 233 PRSSC were included in the study. The detected CG were blaNDM (64%), blaKPC (31%), blaSPM and blaVIM (1% each). The main isolates were: Klebsiella pneumoniae-Kp (49%), Escherichia coli-Ec (16%), Pseudomonas aeruginosa-Pa (16%), Acinetobacter baumannii-Ab (6%) and Enterobacter cloacae (4%). Ninety-six patients had PRSSC for GNB#E: 52 patients with two isolates carrying blaNDM, 24 patients with two isolates carrying blaKPC, 16 patients with GNB#E carrying CG# (one blaNDM and another blaKPC), and another 4 patients with GNB#E carrying CG#: 1 with metallo-type (blaVIM, blaIMP, blaSPM and blaNDM+blaKPC) together with another isolate carrying blaKPC. In 10 patients, 20 GNB=E carrying CG# (10 blaKPC and 10 blaNDM) were recovered, all from the genus Klebsiella. We highlight the presence of PRSSC in six patients with three GNB#E in the same patient, all carrying blaNDM. Kp was the most frequently isolated species, recovered in PRSSC from 105 patients, and blaNDM was the most detected CG across a greater diversity of species.

Conclusion

The data demonstrate the presence of up to three multidrug-resistant GNB#E carrying different carbapenemases in the same patient, confirming that the GM is a reservoir of resistance genes and that surveillance cultures are extremely important for monitoring and controlling the dissemination of these genes.

Keywords:
Epidemiological Surveillance
Gut Microbiota
Carbapenemases
Pharmacological Resistance
PDF
Full text is only available in PDF
Download PDF
The Brazilian Journal of Infectious Diseases
Article options
Tools